Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Vitamin D2 for COVID-19 Prevention
NCT05673980Unknown
- Sponsor
- Peking University Third Hospital
- Start
- Dec 2022
- Primary completion
- Jan 2023
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Randomised, open-label trial of vitamin d in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Peking University Third Hospital. Primary endpoint: Change in incidence of laboratory-confirmed (or COVID-19 antibody test) COVID-19 infection at 4 weeks. Status: unknown.
02
Drugs
vitamin d
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05673980.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05673980.